D.A. Davidson & Co. Grifols Sa Transaction History

D.A. Davidson & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$17.59 - $21.1 $319,029 - $382,690	-18,137 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$18.01 - $20.11 $9,995 - $11,161	-555 Reduced 2.97%	18,137 $365,000
Q4 2018 Jan 29, 2019	SELL	$17.44 - $21.53 $14,824 - $18,300	-850 Reduced 4.35%	18,692 $343,000
Q3 2018 Nov 13, 2018	SELL	$19.97 - $21.96 $13,919 - $15,306	-697 Reduced 3.44%	19,542 $418,000
Q2 2018 Aug 02, 2018	BUY	$20.16 - $24.68 $16,672 - $20,410	827 Added 4.26%	20,239 $435,000
Q1 2018 May 04, 2018	BUY	$20.31 - $24.95 $37,187 - $45,683	1,831 Added 10.41%	19,412 $412,000
Q4 2017 Feb 08, 2018	BUY	$20.99 - $23.89 $24,096 - $27,425	1,148 Added 6.99%	17,581 $403,000
Q3 2017 Nov 08, 2017	BUY	$20.07 - $21.89 $7,185 - $7,836	358 Added 2.23%	16,433 $359,000
Q2 2017 Aug 11, 2017	BUY	N/A	16,075	16,075 $0

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.